On November 20, 2023, the 15th tutorial for Certified Tobacco Cessation Specialists was held, marked by a productive collaboration between Dr. Mariya, Dr. Siddhi, Dr. Anshika, and the new addition to the coordinator team, Dr. Abhishek Bhadranna.
Agenda Highlights:
1. Case Discussion on PAAN Cessation: Dr. Anshika Pandey presented a compelling case of a paan (betel leaf) consumer and shared the successful guidance provided to help the individual quit this habit.
2. Integration of WHO Guidelines on Tobacco and Diabetes: Dr. Rakesh Gupta from SIPHER and Dr. Pawan Gupta led a discussion on the recent WHO guidelines concerning tobacco and its connection to diabetes. They highlighted how ICanCaRe has incorporated these guidelines into the ABCD model for comorbidity management.
3. Turning Tobacco Cessation into a Success Story: Participants engaged in a thoughtful dialogue on transforming tobacco cessation into a successful endeavor. The focus was on building confidence and establishing a strong identity in the field of tobacco cessation. Attendees were tasked with creating their professional identity, including designing visiting cards and flyers.
4. Special Pricing for Tobacco-Related Medications: Information regarding exclusive pricing for tobacco-related medications for CTCS in clinic settings was shared to facilitate more accessible treatment options.
5. Acknowledging ICanCaRe: Dr. Pawan Gupta emphasized the importance of CTCS acknowledging ICanCaRe in all their presentations, both online and offline, to strengthen the collective mission.
Members’ Feedback:
– Siddhi continued to express her appreciation for the ongoing opportunities for learning and professional growth.
– Abhishek expressed gratitude to all participants for their valuable contributions and highlighted the wealth of knowledge gained during the session.
– Rakesh commended the inclusion of comorbidity management into ICanCaRe cessation and emphasized the tutorial’s importance for anyone looking to excel in the field.
– Dr. Rajkumari underscored the tutorial’s role in enhancing learning and skill development.
– Kshipra expressed gratitude for the enriching learning experience.
ICanCaRe Academy Tutorial for Certified Tobacco Cessation Specialists (CTCS) is a monthly program held on the 15th of each month, from 9-10 PM. The program encourages CTCS to present complex cases on tobacco cessation for discussion and finding solutions to facilitate successful quitting. To submit cases or for further information, individuals can contact Dr. Mariya, Dr. Siddhi, Dr. Anshika, or Dr. Abhishek.
ICanCaRe Academy encourages active participation in these monthly sessions to gain profound insights into practical tobacco cessation through case discussions. Aspiring Certified Tobacco Cessation Specialists can explore the certification process at www.icancare.in/academy/ctcs
In a groundbreaking collaboration, the World Health Organization (WHO), the International Diabetes Federation (IDF), and the University of Newcastle have released a policy brief emphasizing the significant health benefits of quitting smoking, particularly in relation to type 2 diabetes.
The Key Findings
– Reduced Risk of Type 2 Diabetes: The brief reveals that individuals who quit smoking can lower their risk of developing type 2 diabetes by an impressive 30-40%. This statistic highlights the profound impact that smoking cessation can have on one’s health, especially considering the prevalence and seriousness of type 2 diabetes.
– Impact on Blood Sugar Regulation: Smoking has been found to influence the body’s ability to regulate blood sugar levels. This dysregulation is a key factor in the development of type 2 diabetes, making smoking cessation a crucial step in mitigating this risk.
The joint policy brief by the WHO, IDF, and the University of Newcastle serves as a critical reminder of the power of lifestyle changes in preventing chronic diseases. For tobacco users, the decision to quit smoking can be a life-changing one, significantly reducing the risk of developing type 2 diabetes and improving overall health. This information is not only crucial for individuals but also for healthcare systems and policymakers, guiding them in creating effective strategies to combat the dual challenges of smoking and diabetes globally.
In light of the significant findings from the joint policy brief by the WHO, IDF, and the University of Newcastle, the relevance of the ICanCaRe Tobacco Cessation Program becomes increasingly important. This program plays a crucial role in facilitating the journey towards a smoke-free life, especially for those at risk of developing type 2 diabetes.
ICanCaRe Tobacco Cessation Program: A Beacon of Hope
1. Personalized Approach: The ICanCaRe program is designed to offer personalized support to individuals seeking to quit Tobacco. Understanding that each journey is unique, the program tailors its strategies to meet the specific needs and challenges of each participant. (www.app.icancare.in)
2. Comprehensive Support System: The program encompasses a range of support mechanisms, including counseling, behavioral therapy, and medical assistance in a protocol based approach provided by Certified Tobacco Cessation Specialists. This multi-faceted ABCD approach for tobacco cessation ensures that individuals have access to all necessary resources to 100% quit smoking or Chewing tobacco. The program is supported by
3. Educational Resources: ICanCaRe books and IEC materials also focus on educating participants about the health risks associated with smoking, including the increased risk of type 2 diabetes. By providing evidence-based information, the program empowers individuals to make informed decisions about their health.
4. Community and Peer Support through TOBACCO MARSHALs: Recognizing the importance of a supportive community, the program trains TOBACCO MARSHALS (www.icancare.in/academy/marshal) to create influence in society.
References and Further Reading
For those interested in delving deeper into the topic, the following references provide valuable insights:
World Health Organization, International Diabetes Federation, and the University of Newcastle. “Policy Brief on Smoking and Type 2 Diabetes.” This brief offers a comprehensive overview of the research linking smoking cessation to a reduced risk of type 2 diabetes.
ICanCaRe. “Tobacco Cessation Program Overview.” www.icancare.in
American Diabetes Association. “The Impact of Smoking on Diabetes and Diabetes Management.” This article discusses the implications of smoking on diabetes management and the benefits of cessation.
National Institute of Diabetes and Digestive and Kidney Diseases. “Smoking and Diabetes.” This resource offers a deeper understanding of how smoking affects diabetes risk and control.
The collaboration between the WHO, IDF, and the University of Newcastle, along with programs like ICanCaRe, highlights the critical intersection of smoking cessation and diabetes prevention. By leveraging these resources and programs, individuals can significantly reduce their risk of type 2 diabetes and improve their overall health, marking a substantial step forward in public health and personal well-being.
The Oral Oncology Connect hosted a transformative workshop themed “Oral Cancer – Journey Re-Defined,” which focused on innovative light treatments in cancer care, such as Photobiomodulation (PBM), Photo-dynamic Therapy, and Photo diagnostics. Held at the Conference Hall, Service Floor, MAX Vaishali, this hybrid event welcomed key speakers and participants from varied domains of healthcare and research to delve deep into the potential of PBM in cancer care. The event, organized by the institute’s Surgical Oncology and Head and Neck Oncology team led by Sr. Director Dr. Pawan Gupta, highlighted the institute’s commitment to pioneering advancements in cancer care. The program was conducted hybridly with the support of ECHO India. The participants included practitioners, students and clinicians around 100 were physically present, and almost the same numbers joined online.
Keynote Speakers included Dr. Praveen R. Arany, Dr. Mallika Sethi Rishi, Dr. Shovan K Majumder, Dr. Rakesh Rawal, Dr. Jyoti Batra, Dr. Poorvee Mathur, Dr. Asad Khan, Dr. Pravesh Singh, and Dr. Manoj Tayal who brought forth their expertise in oral biology, surgery, biomedical engineering, and LED-based photo biomodulation, among other specializations.
The event brought together luminaries Dr. Praveen R. Arany and Dr. Mallika Sethi Rishi, providing valuable insights into the underpinnings and clinical applications of Photobiomodulation (PBM). A key highlight was the hands-on demonstration of PBM equipment, allowing participants to engage with state-of-the-art therapeutic tools.
Another key contribution to the workshop was made by Dr. Shovan K Majumder, a distinguished expert in the field of BIOPHOTONICS. Dr. Majumder, who is a Professor, at Homi Bhabha National Institute (HBNI), Department of Atomic Energy and Head, of the Laser Biomedical Applications Division, Raja Ramanna Centre for Advanced Technology (RRCAT), shared his extensive knowledge and findings of Research and Development carried out in his Group towards the advancement of Photo diagnosis and Phototherapy including Photodynamic Therapy and Photo-biomodulation. His session illuminated the audience on the cutting-edge applications of photonics-based technologies in cancer care, highlighting their potential to improve treatment outcomes and quality of life in patients. The team from RRCAT consists of. Majumder and other scientists of his Group, Dr. Srinivas Satapathy, Dr. Khageswar Sahu, Dr. Rashmi Shrivastav, and Dr. Hemant Krishna presented their extensive research work on various biomedical applications of light and the advanced work being carried out by them in developing photonics-based point-of-care medical instruments.
The agenda for the event was packed with insightful sessions starting from 1:30 PM after lunch, with topics covering molecular mechanisms, dosimetry concepts, and clinical practice guidelines for PBM in cancer care. The discussions were chaired by eminent professionals like Prof. G.K. Rath, Dr. Harit Chaturvedi, Dr. Amitabh Singh, Dr. Amit Verma, Dr. Meenu Walia, Dr. Rahul Singh, Dr. Alok Narang, Dr. Sanjay Labh, Dr. Rajat Saxena and Dr. Srinivas Satapathy set a high standard for academic discourse.
Sessions chaired by respected figures in oncology set a high standard for academic discourse. Dr. Jyoti Batra’s presentation emphasized the importance of inclusive partnerships for improved patient outcomes.
The series was further enriched by the addition of Dr. Asad Khan, who is recognized for conducting the first clinical trials in Photodynamic Therapy (PDT) for infections. Dr. Khan presented his experience, adding a unique perspective on the practical challenges and benefits of PDT in clinical settings.
A hands-on demonstration on PBM instruments was a highlight, spearheaded by Dr. Mallika Sethi, and supported by BIOLASE India Pvt. Ltd. allowing attendees to engage with the latest technology. The event also emphasized the importance of inclusive partnerships for better patient outcomes, a topic presented by Dr. Jyoti Batra of Santosh University.
The workshop concluded with a comprehensive hands-on demonstration of PBM, where participants had the opportunity to experience the practical aspects of this emerging therapeutic modality.
This educational series was a pivotal step in redefining the journey of oral cancer treatment, with a strong focus on patient wellness and quality of life. The event emphasized the critical role of dental care in oncology, reflecting on the severe side effects of cancer treatments, like oral mucositis, and the potential of PBM therapy to mitigate these effects.
Endorsed by associations like MASCC, ISOO, and WALT, PBM’s efficacy in preventing and treating cancer treatment-induced oral mucositis was underscored, reflecting rigorous analysis from numerous studies.
The event was not only a learning platform for oncologists, dentists, and healthcare professionals but also offered profound insights for medical equipment suppliers, researchers, and caregivers, emphasizing the importance of informed treatment decisions.
The Oral Oncology Connect – Education Series was a successful endeavor by ICanCaRe, the MAX Institute of Cancer Care, the Indian Dental Association – East Delhi, ECHO India, and Santosh University, pushing the envelope in cancer care through innovative and cost-effective treatments. The workshop paved the way for further research and application of PBM in clinical settings, marking a significant milestone in patient-centric cancer care.
In summary, the Oral Oncology Connect – Education Series was a collaborative effort led by Dr. Pawan Gupta and his team, showcasing MAX Institute’s role as a leader in patient-centric cancer care and education. The series successfully facilitated a platform for knowledge exchange and set a benchmark for future educational endeavors in the field of oncology.
The event was well conducted by Dr. Sumanth Bholu, Dr. Khyati, Dr. Ghatdeep, and Dr Anshika. Ms. Sanchika Gupta of ECHO India managed the program online.
The entire marketing team of MAX Vaishali Mr. Shahzad, Mr. Sachin, and his team worked hard to make the event a success.
Certificates were given to all participants of the event.
